# DFFB

## Overview
The DFFB gene encodes the DNA fragmentation factor subunit beta, a critical component of the apoptotic pathway. This protein functions as a nuclease within the caspase-activated DNase (CAD) complex, which is activated by caspase-3 during apoptosis. DFFB is responsible for the fragmentation of cell-free DNA (cf.DNA) by creating blunt double-strand breaks, particularly in open internucleosomal regions, with a preference for purine nucleotides. This activity is essential for the nucleosomal patterning of DNA fragments, facilitating the orderly dismantling of cellular components during cell death (Larsen2016The; Han2020The). DFFB interacts with DNA fragmentation factor subunit alpha (DFFA) to form a heterodimeric complex, which is crucial for its function as an apoptotic nuclease (Liu1997DFF). The protein's role in nucleic acid metabolism and its interactions with other apoptosis-related proteins underscore its importance in maintaining genomic stability and its potential as a biomarker in certain cancers (Gao2020<p><em>HNRNPCL1</em>).

## Function
The DFFB gene encodes the DNA fragmentation factor subunit beta, which plays a crucial role in the process of apoptosis, particularly in the fragmentation of cell-free DNA (cf.DNA). DFFB is a major intracellular nuclease responsible for generating A-end fragments by creating blunt double-strand breaks in open internucleosomal DNA regions, with a preference for purine nucleotides such as adenine (A) and guanine (G) (Han2020The). This activity results in a nucleosomal patterning of A<>A, A<>G, and A<>C fragments, which is essential for the nucleosomal periodic cutting of cf.DNA (Han2020The).

DFFB functions as part of the caspase-activated DNase (CAD) complex, which is activated by caspase-3 during apoptosis. This activation leads to DNA fragmentation and chromatin condensation, processes that are critical for the orderly dismantling of cellular components during cell death (Larsen2016The). The activity of DFFB is primarily localized in the nucleus, where it facilitates the breakdown of DNA, ensuring efficient removal of dying cells and maintaining genomic stability (Larsen2016The). The absence of DFFB results in a lack of long A-end fragment enrichment, highlighting its essential role in cf.DNA fragmentation (Han2020The).

## Clinical Significance
Mutations and alterations in the DFFB gene have been implicated in various diseases and conditions. In the context of cancer, DFFB is considered a candidate tumor suppressor gene due to its role in apoptosis. However, exhaustive mutation screening in neuroblastomas and other tumors did not reveal tumor-specific mutations, suggesting that DFFB may not be a significant factor in neuroblastoma pathogenesis (Judson2000Structure). Despite this, a high-frequency mutation site in DFFB has been identified in patients with endometrial cancer, indicating its potential involvement in this type of cancer (&lt; p&gt; HNRNPCL1&lt; /em&gt; Gao2020&lt; em&gt).

In Alzheimer's disease, DFFB has been identified as having a direct causal connection. Experimental models have shown that repressing DFFB can stabilize Alzheimer's processes and decrease neuronal apoptosis, suggesting that upregulation of DFFB may contribute to the disease's pathogenesis (Ni2021Functional). Additionally, alterations in DFFB expression in response to neurotoxic stimuli have been observed in experimental Alzheimer's models, indicating its role in apoptosis and neurodegeneration (Kolobov2012Glutamate).

Overall, while DFFB's role in apoptosis is well-established, its clinical significance in disease contexts requires further investigation to fully understand its impact on disease progression and potential as a therapeutic target.

## Interactions
DFFB, or DNA fragmentation factor subunit beta, is a crucial component in the apoptotic pathway, primarily interacting with DFFA (DNA fragmentation factor subunit alpha) to form a heterodimeric complex. This complex is activated by caspase-3, which cleaves DFFA, allowing DFFB to function as an apoptotic nuclease that facilitates DNA fragmentation during cell death (Liu1997DFF). 

In the context of protein-protein interactions, DFFB is associated with several other proteins involved in apoptosis and DNA fragmentation. It interacts with caspase-3, which is essential for its activation, as caspase-3 cleaves the DFF-45 subunit, a necessary step for DFFB's function in DNA fragmentation (Liu1997DFF). DFFB is also part of a broader network of interactions, as identified in protein-protein interaction analyses, where it is linked to histone cluster 1 H1 family members (HIST1H1B, HIST1H1D, HIST1H1C), high mobility group box proteins (HMGB2, HMGB1), and other apoptosis-related proteins (Gao2020<p><em>HNRNPCL1</em>).

These interactions highlight DFFB's role in nucleic acid metabolism, DNA replication and repair, and transcription regulation, underscoring its importance in the apoptotic pathway and its potential as a biomarker in certain cancers (Gao2020<p><em>HNRNPCL1</em>).


## References


[1. (Larsen2016The) Brian D. Larsen and Claus S. Sørensen. The caspase‐activated <scp>dn</scp>ase: apoptosis and beyond. The FEBS Journal, 284(8):1160–1170, December 2016. URL: http://dx.doi.org/10.1111/febs.13970, doi:10.1111/febs.13970. This article has 137 citations.](https://doi.org/10.1111/febs.13970)

[2. (Han2020The) Diana S.C. Han, Meng Ni, Rebecca W.Y. Chan, Vicken W.H. Chan, Kathy O. Lui, Rossa W.K. Chiu, and Y.M. Dennis Lo. The biology of cell-free dna fragmentation and the roles of dnase1, dnase1l3, and dffb. The American Journal of Human Genetics, 106(2):202–214, February 2020. URL: http://dx.doi.org/10.1016/j.ajhg.2020.01.008, doi:10.1016/j.ajhg.2020.01.008. This article has 142 citations.](https://doi.org/10.1016/j.ajhg.2020.01.008)

[3. (Liu1997DFF) Xuesong Liu, Hua Zou, Clive Slaughter, and Xiaodong Wang. Dff, a heterodimeric protein that functions downstream of caspase-3 to trigger dna fragmentation during apoptosis. Cell, 89(2):175–184, April 1997. URL: http://dx.doi.org/10.1016/s0092-8674(00)80197-x, doi:10.1016/s0092-8674(00)80197-x. This article has 1391 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0092-8674(00)80197-x)

[4. (Judson2000Structure) Hannah Judson, Nadine van Roy, Lisa Strain, Jo Vandesompele, Mireille Van Gele, Frank Speleman, and David T. Bonthron. Structure and mutation analysis of the gene encoding dna fragmentation factor 40 (caspase-activated nuclease), a candidate neuroblastoma tumour suppressor gene. Human Genetics, 106(4):406–413, April 2000. URL: http://dx.doi.org/10.1007/s004390000257, doi:10.1007/s004390000257. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s004390000257)

[5. (Kolobov2012Glutamate) V. V. Kolobov, T. V. Davydova, I. A. Zakharova, V. Yu. Gorbatov, and V. G. Fomina. Glutamate antibodies repress expression of dffb gene in brain of rats in experimental alzheimer’s disease. Molecular Biology, 46(5):678–686, September 2012. URL: http://dx.doi.org/10.1134/S0026893312040061, doi:10.1134/s0026893312040061. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1134/S0026893312040061)

6. (Ni2021Functional) Functional Genetic Biomarkers of Alzheimer’s Disease and Gene Expression from Peripheral Blood. This article has 0 citations.